J&J Seeks Study For Its Vaccine To Be Applied On Adolescents In India

According to the statement given by the US-based pharmaceutical company, Johnson & Johnson notified that it has looked into the approval of the Central Drugs Standard Control Organisation to conduct a study on its Covid-19 vaccine for adolescents between 12-17 years old in India. Being “imperative”, all the nationals including children should be vaccinated against Covid-19 sooner. Besides, their vaccine is 85% effective in presenting diseases including Covid.